GenePath Dx Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 75

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $336K

  • Investors
  • 3

GenePath Dx General Information

Description

Operator of a molecular diagnostics company intended to screen and diagnose diseases. The company offers state-of-the-art in vitro diagnostic assays, test kits and techniques, including molecular diagnostics, for infectious diseases, cancers, and genetic disorders, enabling medical, healthcare and allied communities to get accurate, reliable, rapid, and affordable diagnostics results.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1260/B Jangli Maharaj Road, Plot 596
  • Above Phadke Hospital, across from McDonald Deccan Gymkhana, Shivajinagar
  • Pune, Maharashtra 411016
  • India
+91 020
Primary Industry
Diagnostic Equipment
Other Industries
Laboratory Services (Healthcare)
Vertical(s)
Corporate Office
  • 1260/B Jangli Maharaj Road, Plot 596
  • Above Phadke Hospital, across from McDonald Deccan Gymkhana, Shivajinagar
  • Pune, Maharashtra 411016
  • India
+91 020

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GenePath Dx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 23-Nov-2020 $336K Completed Generating Revenue
4. Later Stage VC 05-Jul-2017 Completed Generating Revenue
3. Later Stage VC 01-Feb-2016 Completed Generating Revenue
2. Later Stage VC 11-Feb-2015 $403K $1.06M Completed Generating Revenue
1. Later Stage VC 28-Aug-2014 $658K $658K Completed Generating Revenue
To view GenePath Dx’s complete valuation and funding history, request access »

GenePath Dx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view GenePath Dx’s complete cap table history, request access »

GenePath Dx Patents

GenePath Dx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4034671-A1 Composition and method for improving detection of biomolecules in biofluid samples Pending 24-Sep-2019
US-20220396824-A1 Composition and method for improving detection of biomolecules in biofluid samples Pending 24-Sep-2019
EP-4034671-A4 Composition and method for improving detection of biomolecules in biofluid samples Pending 24-Sep-2019
US-20220195502-A1 Method for detecting specific nucleic acids in samples Pending 24-Apr-2019
EP-3959337-A1 Method for detecting specific nucleic acids in samples Pending 24-Apr-2019 C12Q1/6827
To view GenePath Dx’s complete patent history, request access »

GenePath Dx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GenePath Dx Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
US India Science and Technology Endowment Fund Limited Partner
Saama Capital Venture Capital Minority
Snow Leopard Ventures Corporate Venture Capital Minority
To view GenePath Dx’s complete investors history, request access »

GenePath Dx FAQs

  • When was GenePath Dx founded?

    GenePath Dx was founded in 2008.

  • Where is GenePath Dx headquartered?

    GenePath Dx is headquartered in Pune, India.

  • What is the size of GenePath Dx?

    GenePath Dx has 75 total employees.

  • What industry is GenePath Dx in?

    GenePath Dx’s primary industry is Diagnostic Equipment.

  • Is GenePath Dx a private or public company?

    GenePath Dx is a Private company.

  • What is GenePath Dx’s current revenue?

    The current revenue for GenePath Dx is .

  • How much funding has GenePath Dx raised over time?

    GenePath Dx has raised $1.36M.

  • Who are GenePath Dx’s investors?

    US India Science and Technology Endowment Fund, Saama Capital, and Snow Leopard Ventures have invested in GenePath Dx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »